Ameritas Advisory Services LLC Purchases New Stake in Mettler-Toledo International, Inc. (NYSE:MTD)

Ameritas Advisory Services LLC purchased a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 672 shares of the medical instruments supplier's stock, valued at approximately $794,000.

Several other institutional investors have also recently bought and sold shares of MTD. Eads & Heald Wealth Management raised its holdings in Mettler-Toledo International by 77.0% during the 1st quarter. Eads & Heald Wealth Management now owns 708 shares of the medical instruments supplier's stock worth $836,000 after purchasing an additional 308 shares during the last quarter. Albion Financial Group UT grew its position in shares of Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after buying an additional 11 shares during the period. K.J. Harrison & Partners Inc bought a new stake in shares of Mettler-Toledo International during the first quarter worth approximately $203,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Mettler-Toledo International by 13.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock valued at $2,929,000 after buying an additional 292 shares during the period. Finally, Illinois Municipal Retirement Fund lifted its holdings in Mettler-Toledo International by 11.5% in the first quarter. Illinois Municipal Retirement Fund now owns 8,196 shares of the medical instruments supplier's stock valued at $9,679,000 after buying an additional 848 shares during the period. Institutional investors own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director owned 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Price Performance

NYSE:MTD traded up $3.43 during trading hours on Thursday, reaching $1,209.08. 41,859 shares of the stock were exchanged, compared to its average volume of 149,905. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The stock has a market cap of $25.12 billion, a PE ratio of 30.15, a PEG ratio of 3.70 and a beta of 1.37. The firm has a 50 day moving average of $1,145.21 and a 200 day moving average of $1,196.62.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating the consensus estimate of $7.90 by $0.29. The company had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. Mettler-Toledo International's revenue for the quarter was down 4.6% compared to the same quarter last year. During the same quarter last year, the company earned $8.89 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Wall Street Zen lowered shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Robert W. Baird decreased their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research note on Tuesday, April 22nd. Finally, Barclays initiated coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target for the company. Eight research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, Mettler-Toledo International presently has a consensus rating of "Hold" and a consensus price target of $1,300.36.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.